Evidence map›Paper›PMID 36897408›Full record

ArticleInternational journal of colorectal disease2023

Adverse impact of tumor deposits in lymph node negative rectal cancer - a national cohort study.

Simon Lundström, Erik Agger, Marie-Louise Lydrup, Fredrik Jörgren, Pamela Buchwald

Open access · hybridFull text read
In one paragraph

Article in International journal of colorectal disease, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Simon LundströmDepartment of Surgery, Skåne University Hospital, Lund University, Malmö, Sweden. simon.lundstrom@med.lu.se.ORCID http://orcid.org/0000-0002-5602-7128
Erik AggerDepartment of Surgery, Skåne University Hospital, Lund University, Malmö, Sweden.ORCID http://orcid.org/0000-0003-4463-2336
Marie-Louise LydrupDepartment of Surgery, Skåne University Hospital, Lund University, Malmö, Sweden.ORCID http://orcid.org/0000-0002-4803-8548
Fredrik JörgrenDepartment of Surgery, Helsingborg Hospital, Lund University, Helsingborg, Sweden.ORCID http://orcid.org/0000-0003-3876-4033
Pamela BuchwaldDepartment of Surgery, Skåne University Hospital, Lund University, Malmö, Sweden.ORCID http://orcid.org/0000-0001-6407-5552
Lund University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis study aimed to investigate the prognostic effect of tumor deposits (TDs) in lymph node negative rectal cancer.

methodsPatients who had undergone surgery for rectal cancer with curative intention between 2011 and 2014 were extracted from the Swedish Colorectal Cancer Registry. Patients with positive lymph nodes, undisclosed TD status, stage IV disease, non-radical resections, or any outcome (local recurrence (LR), distant metastasis (DM) or mortality) within 90 days after surgery were excluded. TDs status was based on histopathological reports. Cox-regression analyses were used to examine the prognostic impact of TDs on LR, DM, and overall survival (OS) in lymph node-negative rectal cancer.

resultsA total of 5455 patients were assessed for inclusion of which 2667 patients were analyzed, with TDs present in 158 patients. TD-positive patients had a lower 5-year DM-free survival (72.8%, p < 0.0001) and 5-year overall survival (75.9%, p = 0.016), but not 5-year LR-free survival (97.6%) compared to TD-negative patients (90.2%, 83.1% and 95.6%, respectively). In multivariable regression analysis, TDs increased the risk of DM [HR 4.06, 95% CI 2.72-6.06, p < 0.001] and reduced the OS [HR 1.83, 95% CI 1.35-2.48, p < 0.001]. For LR, only univariable regression analysis was performed which showed no increased risk of LR [HR 1.88, 95% CI 0.86-4.11, p = 0.11].

conclusionTDs are a negative predictor of DM and OS in lymph node-negative rectal cancer and could be taken into consideration when planning adjuvant treatment.

Indexed as

Extranodal ExtensionRectal NeoplasmsCohort StudiesHumansLymph NodesNeoplasm StagingPrognosisRetrospective StudiesLymph node negative rectal cancerN1cRectal cancerTumor deposits

Identifiers

PMID36897408
PMCPMC10006276
OpenAlexW4323812821

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read45
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.